Memantine for posttraumatic stress disorder in an older veteran

Journal of Clinical Psychopharmacology

Volumn 31, Issue 6, 2011, Pages 787-788

  Chopra, Mohit P ^a   Trevino, Kelly M ^b   Kowall, Neil W ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; MEMANTINE; PRAZOSIN;

AGED; BEDTIME DOSAGE; CASE REPORT; DRUG DOSE TITRATION; FALLING; HIP FRACTURE; HOSPITAL ADMISSION; HUMAN; LETTER; MAINTENANCE DRUG DOSE; MALE; MINI MENTAL STATE EXAMINATION; NIGHTMARE; ORTHOSTATIC HYPOTENSION; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOTHERAPIST; REHABILITATION CARE; TREATMENT DURATION; VETERAN;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; MALE; MEMANTINE; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS;

EID: 80755148743     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31823657bf     Document Type: Letter

References (12)

1. Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007;61:928-934. (Pubitemid 46505008)
2. Wang LY, Shofer JB, Rohde K, et al. Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. Am J Ger Psychiatry. 2009;17:744-751.
3. Carlson EB, Lauderdale S, Hawkins J, et al. Posttraumatic stress and aggression among veterans in long-term care. J Geriatr Psychiatry Neurol. 2008;21:61-71. (Pubitemid 351257762)
4. Battista MA, Hierholzer R, Khouzam HR, et al. Pilot trial of memantine in the treatment of posttraumatic stress disorder. Psychiatry. 2007;70:167-174. (Pubitemid 47195721)
5. Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry. 1999;45: 1226-1229. (Pubitemid 29236566)
6. Stewart SE, Jenike EA, Hezel DM, et al. A single-blinded case-control study of memantine in severe obsessive-compulsive disorder. J Clin Psychopharmacol. 2010;30:34-39.
7. Ravindran LN, Stein MB. Pharmacotherapy of PTSD: premises, principles, and priorities. Brain Res. 2009;1293:24-39.
8. Olff M, de Vries GJ, Guzelcan Y, et al. Changes in cortisol and DHEA plasma levels after psychotherapy for PTSD. Psychoneuroendocrinology. 2007;32: 619-626. (Pubitemid 47017583)
9. Lenze EJ, Mantella RC, Shi P, et al. Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram. Am J Geriatr Psychiatry. 2011;19:482-490.
10. Brunet A, Orr SP, Tremblay J, et al. Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. J Psych Res. 2008;42:503-506. (Pubitemid 351240920)
11. Yaffe K, Vittinghoff E, Lindquist K, et al. Posttraumatic stress disorder and risk of dementia in US veterans. Arch Gen Psychiatry. 2010;67:608-613.
12. Kavirajan H. Memantine: a comprehensive review of safety and efficacy. Expert Opin Drug Saf. 2009;8:89-109.